Professional Documents
Culture Documents
Operating Room Crisis Checklists: Do Not Remove Book From This Room
Operating Room Crisis Checklists: Do Not Remove Book From This Room
SUSPECTED EVENT
>> Do not remove book from this room << Cardiac Arrest – Asystole / PEA 4
Failed Airway 6
Fire 7
Hemorrhage 8
Hypotension 9
Hypoxia 10
Malignant Hyperthermia 11
Based on the OR Crisis Checklists at www.projectcheck.org/crisis. All reasonable precautions have been taken to verify the
information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader.
© 2013–2017 Ariadne Labs: A Joint Center for Health Systems Innovation.
Licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, http://creativecommons.org/licenses/by-nc-sa/4.0/ Revised April 2017 (042417.1)
Tachycardia – Unstable 12
INDEX
1 Air Embolism – Venous
Decreased end-tidal CO2 , decreased oxygen saturation, hypotension
1
5 Consider...
Positioning patient with left side down
• Continue appropriate monitoring while repositioning
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
2 Anaphylaxis
Hypotension, bronchospasm, high peak-airway pressures, decrease or lack of breath sounds, tachycardia, urticaria
7 Consider... • Antibiotics
• Latex products
Turning off volatile anesthetics if patient remains unstable • IV contrast
Epinephrine infusion for patients who initially respond to bolus If cardiac arrest, go to:
doses of epinephrine but experience continued symptoms CHKLST 4 Cardiac Arrest – Asystole / PEA
CHKLST 5 Cardiac Arrest – VF/VT
Diphenhydramine
H2 blockers
Hydrocortisone
Tryptase level: Check within first hour, repeat at 4 hr and at
18 – 24 hrs post reaction
Terminate procedure
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
3 Bradycardia – Unstable
HR < 50 bpm with hypotension, acutely altered mental status, shock, ischemic chest discomfort, or acute heart failure
During RESUSCITATION
Airway: Assess and secure
Circulation: • Confirm adequate IV or IO access
• Consider IV fluids wide open
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
4
Asystole PEA
2 Put backboard under patient, supine position • Start infusion 0.25 – 0.5 mL/kg/min for 30 – 60 minutes
for refractory hypotension
4
3 Turn FiO2 to 100%, turn off volatile anesthetics Beta-blocker: Glucagon 2 – 4 mg IV push
4 Start CPR and assessment cycle... Calcium channel blocker: Calcium chloride 1 g IV
Perform CPR HYPERKALEMIA treatment
• “Hard and fast” about 100 – 120 compressions/min to depth of 2 – 2.3 inches 1. Calcium gluconate • 30 mg/kg IV
• Ensure full chest recoil with minimal interruptions - or -
Calcium chloride • 10 mg/kg IV
• 10 breaths/minute, do not overventilate
2. Insulin • 1 0 units regular IV with
Give epinephrine 1– 2 amps D50W as needed
• Repeat epinephrine every 3 – 5 minutes
3. Sodium bicarbonate if pH < 7.2 • 1– 2 mEq/kg slow IV push
Assess every 2 minutes
• Change CPR compression provider Hs & Ts
• Check ETCO2 • Hydrogen ion • Hypoxia • Toxin
If: < 10 mm Hg, evaluate CPR technique (acidosis) • Tamponade (cardiac) (local anesthetic,
If: Sudden increase to > 40 mm Hg, may indicate return of spontaneous circulation • Hyperkalemia • Tension pneumothorax beta blocker, calcium
• Hypothermia channel blocker)
• Check rhythm; if rhythm organized check pulse • Thrombosis
If: Asystole / PEA continues: • Hypovolemia (coronary/pulmonary)
– Resume CPR and assessment cycle (restart Step 4)
– Read aloud Hs & Ts (see list in right column) During CPR
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
5
VF VT
• Repeat epinephrine every 3 – 5 minutes (acidosis) • Tamponade (cardiac) (local anesthetic,
• Hyperkalemia • Tension pneumothorax beta blocker, calcium
Consider giving antiarrhythmics for refractory VF/ VT • Hypothermia • Thrombosis
channel blocker)
(amiodarone preferred, if available) • Hypovolemia (coronary/pulmonary)
Assess every 2 minutes
• Change CPR compression provider During CPR
• Check ETCO2 Airway: Bag-mask sufficient (if ventilation adequate)
If: < 10 mm Hg, evaluate CPR technique Circulation: • Confirm adequate IV or IO access
If: Sudden increase to > 40 mm Hg, may indicate return of spontaneous circulation • Consider IV fluids wide open
• Treat reversible causes, consider reading aloud Hs & Ts (see list in right column) Assign roles: Chest compressions, Airway, Vascular access,
• Check rhythm; if rhythm organized check pulse Documentation, Code cart, Time keeping
If: VF / VT continues: Resume CPR – defibrillation – assessment cycle (restart Step 4)
If: Asystole / PEA: go to CHKLST 4
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
6 Failed Airway
2 unsuccessful intubation attempts by an airway expert
START
If awakening patient, consider:
• Awake intubation
Still NOT ADEQUATE
• Do procedure under regional/local
Implement surgical airway • Cancel the case
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
7 Fire
Evidence of fire (smoke, odor, flash) on patient or drapes, or in patient’s airway
START
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
8
Acute massive bleeding
Hemorrhage
START
1 Call for help and a code cart 1� Consider... DRUG DOSES and treatments
Ask: “Who will be the crisis manager?” Electrolyte disturbances HYPOCALCEMIA treatment
(hypocalcemia and hyperkalemia) Give calcium to replace deficit
2 Open IV fluids and (calcium chloride or calcium gluconate)
assess for adequate IV access Uncrossmatched type O-neg blood
if crossmatched blood not available
HYPERKALEMIA treatment
3 Turn FiO2 to 100% and Damage control surgery
turn down volatile anesthetics 1. Calcium gluconate • 30 mg/kg IV
(pack, close, resuscitate) - or -
Calcium chloride • 10 mg/kg IV
4 Call blood bank Special patient populations
(see considerations below) 2. Insulin • 10 units regular
Activate massive transfusion protocol
IV with 1– 2 amps
Assign 1 person as primary contact D50W as needed
for blood bank
3. Sodium bicarbonate • 1 – 2 mEq/kg
Order blood products (in addition if pH < 7.2 slow IV push
to PRBCs)
• 1 FFP : 1 PRBC
• If indicated, 6 units of platelets SPECIAL PATIENT POPULATIONS
OBSTETRIC: TRAUMA: NON-SURGICAL 8
5 Request rapid infuser (or pressure bags) • Empirical administration of 1 pool of Give either...
UNCONTROLLED BLEEDING
despite massive transfusion of
6 Discuss management plan between cryoprecipitate (10 cryo units) • Antifibrinolytic tranexamic acid:
PRBC, FFP, platelets and cryo:
surgical, anesthesiology, and nursing teams • Check fibrinogen (goal is 200 mg/dL) 1000 mg IV over 10 minutes
followed by 1000 mg over the • Consider giving Recombinant
< 100 Order 2 more pools next 8 hours Factor VIIa: 40 mcg/kg IV
7 Call for surgery consultation mg/dL of cryoprecipitate – or – – Surgical bleeding must first
8 Keep patient warm 100 – 200 Order 1 more pool • Aminocaproic acid: 4 – 5 g in
be controlled
mg/dL of cryoprecipitate 250 mL NS/RL IV over first – use with CAUTION in
9 Send labs hour followed by a continuing patients at risk for thrombosis
CBC, PT / PTT / INR, fibrinogen, lactate, infusion of 1 g in 50 mL NS/RL – DO NOT use
arterial blood gas, potassium, and ionized calcium IV per hour over 8 hours when PH is < 7.2
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
9 Hypotension
Unexplained drop in blood pressure refractory to initial treatment
START
DRUG DOSES and treatments
1 Call for help and a code cart 7 Consider actions... Ephedrine: 5 – 25 mg IV, repeat as needed
Ask: “Who will be the crisis manager?” Place patient in Phenylephrine: 80 – 200 mcg IV, repeat as needed
Trendelenberg position Epinephrine: BOLUS: 4 – 8 mcg IV
2 Check... (dilute 1 mg in 250 mL = 4 mcg/mL)
Obtain additional IV access
Pulse INFUSION: 0.1 – 1 mcg/kg/min IV
Place arterial line
Blood pressure
Equipment 8 Consider causes...
Heart rate Operative field Breathing
• If BRADYCARDIA, go to CHKLST 3 • Mechanical or surgical manipulation • Increased PEEP
• Insufflation during laparoscopy • Hypoventilation
Rhythm
• Retraction • Hypoxia go to CHKLST 10
• If VF / VT, go to CHKLST 5
• Vagal stimulation • Persistent hyperventilation
• If PEA, go to CHKLST 4
• Vascular compression • Pneumothorax
SIGNIFICANT / REFRACTORY hypotension:
• Internal bleeding • Malignant hyperthermia go to CHKLST 11
• Tachycardia go to CHKLST 12
9
Give epinephrine bolus, consider starting Drugs / Allergy
• Bone cementing (methylmethacrylate effect)
epinephrine infusion • Anaphylaxis go to CHKLST 2
• Myocardial ischemia
• Recent drugs given
• Emboli (pulmonary, fat, septic, amniotic, CO2)
5 Turn FiO2 to 100% and • Dose error
• Severe sepsis
turn down volatile anesthetics • Drugs used on the field
• Tamponade
(i.e., intravascular injection of local
6 Inspect surgical field for bleeding anesthetic drugs)
• If BLEEDING, go to CHKLST 8 • Wrong drug
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
10 Hypoxia
Unexplained oxygen desaturation
START
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
11 Malignant Hyperthermia
In presence of triggering agent: unexpected, unexplained increase in end-tidal CO2 , unexplained tachycardia/tachypnea,
prolonged masseter muscle spasm after succinylcholine. Hyperthermia is a late sign.
8 Hyperventilate patient at flows of • Infuse cold saline intravenously Insulin • 10 units regular IV
10 L / min or more Place Foley catheter, • 1 – 2 amps D50W
monitor urine output
9 Terminate procedure, if possible TRIGGERING AGENTS
Call ICU
• Inhalational anesthetics • Succinylcholine
1� Give dantrolene
1� Give bicarbonate for suspected DIFFERENTIAL diagnosis (consider when using high doses of dantrolene without resolution of symptoms)
metabolic acidosis (maintain pH > 7.2) Cardiorespiratory Iatrogenic Neurologic Toxicology
• Hypoventilation • Exogenous CO2 source • Meningitis • Radiologic contrast neurotoxicity
1� Treat hyperkalemia, if suspected • Sepsis (e.g., laparoscopy) • Intracranial bleed • Anticholinergic syndrome
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)
INDEX
12 Tachycardia – Unstable
Persistent tachycardia with hypotension, ischemic chest pain, altered mental status or shock
12
All reasonable precautions have been taken to verify the information contained in this publication. The responsibility for the interpretation and use of the materials lies with the reader. Revised April 2017 (042417.1)